Status:
ACTIVE_NOT_RECRUITING
Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
PHASE1
Brief Summary
This trial studies the side effects and best way to perform genetic testing in predicting biomarkers of recurrence in patients with prostate cancer undergoing surgery. Collecting and storing samples o...
Detailed Description
PRIMARY OBJECTIVES: I. To explore the performance of these models in predicting the likelihood of biochemical recurrence (BCR). SECONDARY OBJECTIVES: I. To explore the performance of these models in ...
Eligibility Criteria
Inclusion
- \- All men undergoing robotic prostatectomy or cystoprostatectomy at City of Hope will be eligible for the study
Exclusion
- \- Men who undergo neoadjuvant treatment with Androgen Deprivation Therapy (ADT) or salvage prostatectomy including those who have had brachytherapy will be excluded
Key Trial Info
Start Date :
November 26 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 8 2026
Estimated Enrollment :
1045 Patients enrolled
Trial Details
Trial ID
NCT00977457
Start Date
November 26 2007
End Date
July 8 2026
Last Update
August 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope Medical Center
Duarte, California, United States, 91010-3000